Doha, May 27 (QNA) - Sidra Medicine, a member of Qatar Foundation, is the first hospital in the Middle East to successfully perform two Intraventricular Baclofen Therapies. The milestone highlights Sidra Medicine's commitment to pioneering advanced neurosurgical treatments for children and young people with severe movement disorders.

The procedure was performed on two young people with Dystonia. Dystonia is a neurological condition that causes uncontrolled muscle contractions. Following the procedure at Sidra Medicine, both adolescents experienced a remarkable improvement in their condition, demonstrating the effectiveness of this innovative therapy.

Dr. Ian Pople, Chief of Neurosurgery at Sidra Medicine, who led the procedure and emphasized its significance said: "The neurosurgery performed on both patients was highly successful. Unlike traditional intrathecal Baclofen therapy, which delivers the drug into the spinal fluid via a pump in the lower back, the intraventricular approach administers the medication directly into the brain's ventricles, allowing for more effective treatment of severe dystonia affecting the entire body. This approach underscores the importance of integrating neurosurgical precision with rehabilitation, ensuring patients receive the most advanced care available."

Intraventricular Baclofen Therapy begins with the placement of a ventricular reservoir to allow for a trial of Baclofen therapy. This minimally invasive procedure is performed in the operating room using neuronavigational equipment, and the patient stays overnight for monitoring.

Once the surgical site has healed, the patient undergoes a three-day trial in the neurosurgical ward, where an external pump delivers Baclofen similarly to the fully implanted device. Regular assessments help determine the patient's response to the medication. If the trial is successful, a permanent Baclofen pump is implanted to provide continuous therapy. The dosage is gradually adjusted to optimize symptom control, significantly improving the patient's quality of life.

Sidra Medicine features Qatar's first pediatric-focused Movement Disorders Clinic, offering advanced care for children and young people with spasticity (uncontrollable muscle stiffness) and dystonia. The clinic takes a multidisciplinary approach, with specialists in rehabilitation medicine, neurology, neurosurgery, and therapy. It provides surgical and non-surgical interventions for patients who have not responded to medications and conventional therapy. The clinic is a key part of Sidra Medicine's commitment to pioneering pediatric neurology care.

Adam was one of the young patients who underwent the groundbreaking Intraventricular Baclofen Therapies at Sidra Medicine.

Speaking about the impact of the treatment, Adam's mother said: "Before the surgery, Adam's condition affected nearly every part of his day.آ His limbs moved constantly, making it difficult for him to concentrate, rest, or participate in school like other children his age."

"After his surgery at Sidra Medicine and thanks to the Movement Disorders Clinic, Adam's movements began to settle, and he gained a level of control we had not seen in years. These small improvements transformed how he interacts with the world. It has brought hope back into our home, and I truly believe this procedure and the supporting rehabilitative support can help many more children like Adam."

Sidra Medicine's Neurosurgery Department specializes in treating a wide range of neurological conditions, including hydrocephalus, congenital abnormalities, brain and spinal tumors, epilepsy, craniofacial disorders, and spinal conditions. The hospital's use of cutting-edge technology, combined with a patient-centered approach, ensures that children receive world-class care tailored to their individual needs. (QNA)